Clinical Trials Logo

Filter by:
NCT ID: NCT04103255 Completed - Parkinson Disease Clinical Trials

High Frequency and Intensive Prevention Program

Start date: July 10, 2020
Phase: N/A
Study type: Interventional

The treatment of PD has made considerable advances in recent years with respect to drug therapies, as well as many new physiotherapy and drug-based methods, and there have also been great improvements in therapy thanks to deep brain stimulation. Cognitive rehabilitation has shown to be effective in PD (Abbruzzese et al., 2016), however, there has yet to be a major breakthrough in the treatment and prevention of PDD (Parkinson's Disease Dementia ). This is where the high frequency and intensive prevention described here comes into play.

NCT ID: NCT04103242 Not yet recruiting - Infertility, Female Clinical Trials

Abundance of Lactobacillus in Endometrium Affected by Chronic Endometritis

endoMB
Start date: July 1, 2020
Phase:
Study type: Observational

Infertile women undergoing hysteroscopy for diagnostic or therapeutic indication are asked to donate a sample of endometrium. Endometrial samples of study participants are examined for signs of chronic endometritis by immunohistochemical analysis. High-throughput sequencing of the microbial 16s ribosomal ribonucleic acid (rRNA) subunit is performed to identify and quantify the microbes present in the sample. Obstetric and reproductive outcome is recorded 12 months after hysteroscopy (telephone interview).

NCT ID: NCT04102488 Completed - Hand Hygiene Clinical Trials

Simplifying the World Health Organization (WHO) Protocol for Hand Hygiene: Three Steps and 15 Seconds

SIHAG II
Start date: September 15, 2019
Phase: N/A
Study type: Interventional

This study is to investigate that non-inferiority in terms of reduction of bacterial counts will be retained when combining the simpler three-step technique for the use of hand rub with a shorter application time of 15 seconds.

NCT ID: NCT04100213 Recruiting - Clinical trials for Stress, Psychological

Real-Time Assessment of Stress and Stress Response

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Stress is a complex natural phenomenon, frequently related to a physiological response, including heart rate, heart rate variability, respiratory rate, skin conductance and temperature. The subjective experience varies greatly; broadly, it may be conceived as a freeze, flight, fight, fright or faint response. Many studies have demonstrated the negative influence of psychological stress on health and well-being. Through the digital phenotyping of physiological and psychological stress reactions, in a controlled laboratory setting (Trier Social Stress Test- TSST) and real-life situations, in a population of healthy participants and patients with a major psychiatric disorder, we expect to find reliable and valid digital biomarkers. The results of this study will, therefore, not only contribute to a better understanding of stress and stress response but also have the potential to improve diagnostic and treatment approaches.

NCT ID: NCT04099940 Recruiting - Schizophrenia Clinical Trials

Virtual Reality Avatar Therapy for People Hearing Voices

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Hearing voices is probably the worst form of acoustic hallucinations; which can be experienced as severely disturbing and is influenced by diverse factors including the ability of the individual to influence and control the hallucinatory experience itself. In recent years virtual reality has become a treatment option. In the so-called AVATAR Therapy, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent. Avatar Therapy involves similar processes to learning and cognitive restructuring, comparable to other psychotherapeutic interventions. The investigators plan to conduct an interventional study using a cross-over design, to compare the feasibility and efficacy of virtual reality avatar therapy for patients with acoustic hallucinations (independent of psychiatric diagnosis) with a cognitive behavioural group therapy aimed to improve social competence.

NCT ID: NCT04099251 Active, not recruiting - Melanoma Clinical Trials

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

CheckMate76K
Start date: October 28, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effectiveness of nivolumab adjuvant immunotherapy compared to placebo in adults and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recurrence.

NCT ID: NCT04098328 Terminated - Clinical trials for Mitral Regurgitation

Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation

EXPLORE MR
Start date: January 1, 2020
Phase:
Study type: Observational [Patient Registry]

Early feasibility study, single-arm registry design

NCT ID: NCT04098146 Recruiting - Clinical trials for Mandibular Reconstruction

Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection

Start date: September 12, 2022
Phase:
Study type: Observational [Patient Registry]

Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 4 cm secondary to OSSC removal and who require mandibular reconstruction.

NCT ID: NCT04098133 Recruiting - Infections With CPB Clinical Trials

Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital

CPB-Epi Basel
Start date: August 22, 2019
Phase:
Study type: Observational

This retrospective and prospective study is to investigate the incidence of Carbapenemase-producing bacteria (CPB) at the University Hospital Basel, the time to detection of CPB and to initiation of infection control measures, the risk factors associated with carriage of CPB, type and duration of previously administrated antibiotic medication, antibiotic treatment, as well as to assess the outcomes of the affected patients.

NCT ID: NCT04097821 Active, not recruiting - Myelofibrosis Clinical Trials

Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients

ADORE
Start date: September 26, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigate the safety, pharmacokinetics and preliminary efficacy of combination treatment of ruxolitinib with 5 novel compounds: siremadlin, crizanlizumab, sabatolimab, rineterkib and NIS793 in myelofibrosis (MF) subjects.